Innovacell Inc
PublicInnovacell Inc is now publicly traded
The data on this page reflects Innovacell Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series D
Aug 21, 2025
Total Funding Raised
$80.9M
Company Overview
Innovacell Inc has raised $80.9M. It was founded in 2021.
Innovacell Inc is a biotechnology company that develops, produces, and markets regenerative cell therapies for the treatment of fecal and urinary incontinence.
AI Layer
Non-AI
Innovacell Inc Comparables
Compare Innovacell Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MUVON Therapeutics | 78% | |
| Dignify Therapeutics | 53% | |
| Flying Cell | 51% |
For institutional investors. Book with your work email.
Innovacell Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 21, 2025 | ||||
| Series C | Jul 21, 2022 | ||||
| Series A | Apr 26, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Innovacell Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Happiness Capital | Series D |
| M&G Investments | Series D |
| Yokohama Capital Co., Ltd. | Series C |
| SBI Investment Co., Ltd. | Series D, Series C |
Innovacell Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.